Profile
Jason Colquitt is currently a Director at Rare-X.
Previously, he worked as a Vice President-Data Services at Greenway Health, Inc. He obtained his undergraduate degree from Auburn University.
Jason Colquitt active positions
| Companies | Position | Start |
|---|---|---|
Rare-X
 Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Director/Board Member | - |
Former positions of Jason Colquitt
| Companies | Position | End |
|---|---|---|
Greenway Health, Inc.
 Greenway Health, Inc. Information Technology ServicesTechnology Services Greenway Health, Inc. provides technical solutions and services for healthcare customers. It offers electronic healthcare record, practice management, and clearinghouse services. The company was founded by Thomas W. Green Jr. in 1989 and is headquartered in Tampa, FL. | Corporate Officer/Principal | - |
Training of Jason Colquitt
| Auburn University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Greenway Health, Inc.
Greenway Health, Inc. Information Technology ServicesTechnology Services Greenway Health, Inc. provides technical solutions and services for healthcare customers. It offers electronic healthcare record, practice management, and clearinghouse services. The company was founded by Thomas W. Green Jr. in 1989 and is headquartered in Tampa, FL. | Technology Services |
Rare-X
Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Technology Services |
- Stock Market
- Insiders
- Jason Colquitt
